Jones Financial Companies
CATX icon

Jones Financial Companies’s Perspective Therapeutics CATX Stock Holding History

Jones Financial Companies’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68K Sell
881
-140
-14% -$529 ﹤0.01% 4345
2026
Q1 		$4.16K Buy
1,021
+881
+629% +$3.72K ﹤0.01% 3912
2025
Q4 		$385 Hold
140
– – ﹤0.01% 4200
2025
Q3 		$476 Hold
140
– – ﹤0.01% 4041
2025
Q2 		$526 Buy
+140
New +$370 ﹤0.01% 3798

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Jones Financial Companies's CATX Position: Q2 2026 in Review

Jones Financial Companies reduced its Perspective Therapeutics (CATX) stake by 14% in Q2 2026, selling an estimated $529 and leaving 881 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4345.

Jones Financial Companies first reported a position in CATX in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.16K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Jones Financial Companies held 881 shares of Perspective Therapeutics worth $2.68K as of Q2 2026.
  • Jones Financial Companies sold 140 Perspective Therapeutics shares in Q2 2026, an estimated $529.
  • Perspective Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4345 holding.
  • Jones Financial Companies first reported a position in Perspective Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Perspective Therapeutics position peaked at $4.16K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.